Moving People


/ News / Article

  • GNA

EU to order up to 300 million more doses of Moderna Coronavirus shot

The European Commission has struck a deal with US pharmaceutical giant Moderna to buy up to 300 million additional doses of their COVID-19 vaccine, President Ursula von der Leyen announced.

According to the EU executive, which negotiates contracts with vaccine producers on behalf of the 27 member states, the deal provides 150 million doses this year and an option to snap up another 150 million doses in 2022.

Approved in early January, Moderna's drug was the second of three to be green-lighted for use in the EU. The commission's first order for 160 million doses of vaccine, which requires two shots for inoculation, was made in November.

Like the drug made by fellow producer Pfizer/BioNTech, Moderna's shot offers a high level of protection against the deadly respiratory disease: Clinical trials showed over 90-per-cent efficacy.

It is easier to handle than Pfizer/BioNTech's shot, but still much more complex to transport and more expensive than the third EU-approved jab, made by AstraZeneca.


Subscribe and keep up to date with all the latest news from Oakmark

Subtle Shapes Transparent

Oakmark Global Vision provides a bespoke business package to established corporate bodies, investors, and entrepreneurs who desire to enter the West & Pan African market. Find out more >

© 2021 Oakmark Global Vision Ltd - All Rights Reserved.

UK Company No. 07634879 / Nigeria Company No. RC 1288232

Regional Office

International Office

1 Kandi Close, Off Aminu Kano

Crescent, Wuse 2, Abuja F.C.T


+234 -(0)- 929 207 02

+234 (0) 704 497 6500

King Court, 17 School Road

Hall Green, Birmingham

United Kingdom  B28, 8JG

+44 (0) 121 244 1814

+44 (0) 746 625 2505

 Oakmark Global Vision Limited